Regencell Bioscience/$RGC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Regencell Bioscience
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Ticker
$RGC
Sector
Primary listing
Employees
10
Headquarters
Causeway Bay, Hong Kong
Website
RGC Metrics
BasicAdvanced
$2.5bn
-
-$0.01
1.64
-
Price and volume
Market cap
$2.5bn
Beta
1.64
52-week high
$69.00
52-week low
$4.92
Average daily volume
408k
Financial strength
Current ratio
1.415
Quick ratio
1.415
Long term debt to equity
10.512
Total debt to equity
31.68
Interest coverage (TTM)
-70.10%
Profitability
EBITDA (TTM)
-7.066
Management effectiveness
Return on assets (TTM)
-84.97%
Return on equity (TTM)
-177.66%
Valuation
Price to book
2,048.68
Price to tangible book (TTM)
2,048.68
Price to free cash flow (TTM)
-601.19
Free cash flow yield (TTM)
-0.17%
Free cash flow per share (TTM)
-0.008
Growth
Earnings per share change (TTM)
72.40%
3-year earnings per share growth (CAGR)
-0.14%
RGC Financial Performance
Revenues and expenses
RGC News
AllArticlesVideos
Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Business Wire·3 weeks ago
Deadline Soon: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Business Wire·3 weeks ago
Relevant Gold Announces Results of Annual and Special General Meeting and Welcomes New Board Member
Accesswire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.